Tempol reduces oxidative stress and restores renal dopamine D 1-like receptor-G protein coupling and function in hyperglycemic rats

American Journal of Physiology - Renal Physiology

Volumn 291, Issue 1, 2006, Pages

  Marwaha, Aditi ^a   Lokhandwala, Mustafa F ^a  

^a UNIVERSITY OF HOUSTON   (United States)

Author keywords

Antioxidant; G protein receptor kinases; Protein kinase C; SKF 38393; Streptozotocin

Indexed keywords

2,3,4,5 TETRAHYDRO 7,8 DIHYDROXY 1 PHENYL 1H 3 BENZAZEPINE; 8 CHLORO 2,3,4,5 TETRAHYDRO 3 METHYL 5 PHENYL 1H 3 BENZAZEPIN 7 OL HYDROGEN MALEATE; ADENOSINE TRIPHOSPHATASE (POTASSIUM SODIUM); DOPAMINE; DOPAMINE 1 RECEPTOR; G PROTEIN RECEPTOR KINASE; GUANINE NUCLEOTIDE BINDING PROTEIN; PHOSPHOTRANSFERASE; PROTEIN KINASE C; RADIOLIGAND; STREPTOZOCIN; TEMPOL; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIOXIDANT ACTIVITY; ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; ENZYME ACTIVITY; EXPERIMENTAL MODEL; HYPERGLYCEMIA; IMMUNOBLOTTING; IMMUNOPRECIPITATION; KIDNEY; KIDNEY PROXIMAL TUBULE; LIGAND BINDING; LIPID PEROXIDATION; NONHUMAN; OXIDATIVE STRESS; PHOSPHORYLATION; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; WESTERN BLOTTING;

EID: 33745428103     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00362.2005     Document Type: Article

References (46)

1. 1A dopamine receptor in the pathogenesis of genetic hypertension. J Clin Invest 97: 2283-2288, 1996.
2. Aperia AC. Intrarenal dopamine: a key signal in the interactive regulation of sodium metabolism. Annu Rev Physiol 62: 621-647, 2000.
3. 1A receptors in proximal tubules of old Fischer 344 rats. Am J Physiol Renal Physiol 283: F350-F355, 2002.
4. Asghar M, Hussain T, and Lokhandwala MF. Overexpression of PKC-βI and -δ contributes to higher PKC activity in the proximal tubules of old Fischer 344 rats. Am J Physiol Renal Physiol 285: F1100-F1107, 2003.
5. Asghar M and Lokhandwala MF. Antioxidant supplementation normalizes elevated protein kinase C activity in the proximal tubules of old rats. Exp Biol Med (Maywood) 229: 270-275, 2004.
6. i transport in OK cells? J Am Soc Nephrol 9: 1604-1612, 1998.
7. 1 receptor-G protein coupling and function in obese Zucker rats. Diabetes 54: 2219-2226, 2005.
8. Baud L and Ardaillou R. Reactive oxygen species: production and role in the kidney. Am J Physiol Renal Fluid Electrolyte Physiol 251: F765-F776, 1986.
9. 1-like receptor-signaling pathway. Kidney Int 58: 712-720, 2000.
10. Blendea MC, Jacobs D, Stump CS, McFarlane SI, Ogrin C, Bahtyiar G, Stas S, Kumar P, Sha Q, Ferrario CM, and Sowers JR. Abrogation of oxidative stress improves insulin sensitivity in the Ren-2 rat model of tissue angiotensin II overexpression. Am J Physiol Endocrinol Metab 288: E353-E359, 2005.
11. Chen C, Beach RE, and Lokhandwala MF. Dopamine fails to inhibit renal tubular sodium pump in hypertensive rats. Hypertension 21: 364-372, 1993.
12. Cooper ME. Interaction of metabolic and haemodynamic factors in mediating experimental diabetic nephropathy. Diabetologia 44: 1957-1972, 2001.
13. Diamond JR. The role of reactive oxygen species in animal models of glomerular disease. Am J Kidney Dis 19: 292-300, 1992.
14. Dobashi K, Asayama K, Hayashibe H, Uchida N, Kobayashi M, Kawaoi A, and Kato K. Effect of diabetes mellitus induced by streptozotocin on renal superoxide dismutases in the rat. A radioimmunoassay and immunohistochemical study. Virchows Arch B Cell Pathol Incl Mol Pathol 60: 67-72, 1991.
15. + exchanger activity in renal BBMV by stimulation of adenylate cyclase. Am J Physiol Renal Fluid Electrolyte Physiol 259: F297-F303, 1990.
16. Felder RA, Sanada H, Xu J, Yu PY, Wang Z, Watanabe H, Asico LD, Wang W, Zheng S, Yamaguchi I, Williams SM, Gainer J, Brown NJ, Hazen-Martin D, Wong LJ, Robillard JE, Carey RM, Eisner GM, and Jose PA. G protein-coupled receptor kinase 4 gene variants in human essential hypertension. Proc Natl Acad Sci USA 99: 3872-3877, 2002.
17. Hasbi A, Devost D, Laporte SA, and Zingg HH. Real time detection of interactions between the human oxytocin receptor and G protein-coupled receptor kinase-2. Mol Endocrinol 18: 1277-1286, 2004.
18. Hoagland KM, Maier KG, and Roman RJ. Contributions of 20-HETE to the antihypertensive effects of tempol in Dahl salt-sensitive rats. Hypertension 41: 697-702, 2003.
19. Horie K, Miyata T, Maeda K, Miyata S, Sugiyama S, Sakai H, van Ypersole de Strihou C, Monnier VM, Witztum JL, and Kurokawa K. Immunohistochemical colocalization of glycoxidation products and lipid peroxidation products in diabetic renal glomerular lesions. Implication for glycoxidative stress in the pathogenesis of diabetic nephropathy. J Clin Invest 100: 2995-3004, 1997.
20. A1 receptor coupling with GS and Gq/11 proteins in spontaneously hypertensive rats. Am J Physiol Renal Physiol 272: F339-F346, 1997.
21. Hussain T and Lokhandwala MF. Renal dopamine receptor function in hypertension. Hypertension 32: 187-197, 1998.
22. Hussain T and Lokhandwala MF. Renal dopamine receptors and hypertension. Exp Biol Med (Maywood) 228: 134-142, 2003.
23. Hussain T, Beheray SA, and Lokhandwala MF. Defective dopamine receptor function in proximal tubules of obese Zucker rats. Hypertension 34: 1091-1096, 1999.
24. Jose PA, Eisner GM, and Felder RA. Renal dopamine receptors in health and hypertension. Pharmacol Ther 80: 149-182, 1998.
25. Krasel C, Dammeier S, Winstel R, Brockmann J, Mischak H, and Lohse MJ. Phosphorylation of GRK2 by protein kinase C abolishes its inhibition by calmodulin. J Biol Chem 276: 1911-1915, 2001.
26. - cotransporter in rabbits and normotensive rats but not in spontaneously hypertensive rats. Kidney Int 57: 534-543, 2000.
27. Lal MA, Korner A, Matsuo Y, Zelenin S, Cheng SX, Jaremko G, DiBona GF, Eklof AC, and Aperia A. Combined antioxidant and COMT inhibitor treatment reverses renal abnormalities in diabetic rats. Diabetes 49: 1381-1389, 2000.
28. LeClaire MM, Berndt TJ, and Knox FG. Effect of renal interstitial infusion of L-DOPA on sodium and phosphate excretions. J Lab Clin Med 132: 308-312, 1998.
29. 1 receptor function in streptozotocin-induced diabetic rats. Am J Physiol Renal Physiol 286: F451-F457, 2004.
30. Melhem MF, Craven PA, and Derubertis FR. Effects of dietary supplementation of alpha-lipoic acid on early glomerular injury in diabetes mellitus. J Am Soc Nephrol 12: 124-133, 2001.
31. Melhem MF, Craven PA, Liachenko J, and DeRubertis FR. α-Lipoic acid attenuates hyperglycemia and prevents glomerular mesangial matrix expansion in diabetes. J Am Soc Nephrol 13: 108-116, 2002.
32. Nassar T, Kadery B, Lotan C, Da'as N, Kleinman Y, and Haj-Yehia A. Effects of the superoxide dismutase-mimetic compound tempol on endothelial dysfunction in streptozotocin-induced diabetic rats. Eur J Pharmacol 436: 111-118, 2002.
33. Nath KA and Salahudeen AK. Induction of renal growth and injury in the intact rat kidney by dietary deficiency of antioxidants. J Clin Invest 86: 1179-1192, 1990.
34. Nishikawa T, Edelstein D, Du XL, Yamagishi SI, Matsumura T, Kaneda Y, Yorek MA, Beebe D, Oates PJ, Hammes HP, Giardino I, and Brownlee M. Normalizing mitochondrial superoxide production blocks three pathways of hyperglycaemic damage. Nature 404: 787-790, 2000.
35. Penn RB, Pronin AN, and Benovic JL. Regulation of G protein-coupled receptor kinases. Trends Cardiovasc Med 10: 81-89, 2000.
36. Sanada H, Jose PA, Hazen-Martin D, Yu PY, Xu J, Bruns DE, Phipps J, Carey RM, and Felder RA. Dopamine-1 receptor coupling defect in renal proximal tubule cells in hypertension. Hypertension 33: 1036-1042, 1999.
37. Schnackenberg CG and Wilcox CS. The SOD mimetic tempol restores vasodilation in afferent arterioles of experimental diabetes. Kidney Int 59: 1859-1864, 2001.
38. 2α. Hypertension 33: 424-428, 1999.
39. Shah G, Pinnas JL, Lung CC, Mahmoud S, and Mooradian AD. Tissue-specific distribution of malondialdehyde modified proteins in diabetes mellitus. Life Sci 55: 1343-1349, 1994.
40. Shah SV. Role of reactive oxygen metabolites in experimental glomerular disease. Kidney Int 35: 1093-1106, 1989.
41. Tanaka Y, Gleason CE, Tran PO, Harmon JS, and Robertson RP. Prevention of glucose toxicity in HIT-T15 cells and Zucker diabetic fatty rats by antioxidants. Proc Natl Acad Sci USA 96: 10857-10862, 1999.
42. Trachtman H, Futterweit S, Maesaka J, Ma C, Valderrama E, Fuchs A, Tarectecan AA, Rao PS, Sturman JA, and Boles TH. Taurine ameliorates chronic streptozocin-induced diabetic nephropathy in rats. Am J Physiol Renal Fluid Electrolyte Physiol 269: F429-F438, 1995.
43. 1A receptor-Gs-protein coupling by reducing receptor hyper-phosphorylation in obese rats. Am J Physiol Renal Physiol 289: F298-F304, 2005.
44. Varvarovska J, Racek J, Stetina R, Sykora J, Pomahacova R, Rusavy Z, Lacigova S, Trefil L, Siala K, and Stozicky F. Aspects of oxidative stress in children with type 1 diabetes mellitus. Biomed Pharmacother 58: 539-545, 2004.
45. Winstel R, Freund S, Krasel C, Hoppe E, and Lohse MJ. Protein kinase cross-talk: membrane targeting of the β-adrenergic receptor kinase by protein kinase C. Proc Natl Acad Sci USA 93: 2105-2109, 1996.
46. Yu P, Asico LD, Hopfer U, Felder RA, and Jose PA. Direct evidence for D1 dopamine receptor defect in spontaneous hypertension (Abstract). J Am Soc Nephrol 11: 344A, 2000.